Exciting new antibody targets all cancers, starting with AML; clinical trials at Oxford University a

stemcellbuff Member Posts: 1
edited November 2013 in Leukemia #1

The first drug to target a mutation common to all cancers goes to trial soon in the US and UK, Stanford and Oxford. Solid cancers in one trial, AML in the other. Trial headed by stem cell pioneer Irving Weissman of Stanford Univerity.  Many peer reviewed journal papers are mentioned at below link for review. Good luck!



  • GSRon
    GSRon Member Posts: 1,303 Member

    Hi All..!!  Yes CD47 brings a lot of hope for many kinds of Cancer.  The first human testing was to start this year.. then early next year.. now mid 2014.  Check out this link..  http://stemcell.stanford.edu/CD47/


    Be Well All..!


    Ron mRCC